Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001703057-23-000044

Chief Executive Officer acquired 56,125 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Hansen Carl L. G. Chief Executive Officer 2023-11-23 Option exercise +56,125 $2.70 $151,538 673,500 D
Derivatives
Hansen Carl L. G. Chief Executive Officer 2023-11-23 Option exercise · Share option (right to buy) −56,125 6,389,191 D
Loading xslF345X05/wk-form4_1701121501.xml…